🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 18/10/1996 | 35,78 | 36,38 | 35,60 | 35,96 | +0,67% | 2,17% | 8.156.584 |
| 17/10/1996 | 34,65 | 35,78 | 34,65 | 35,72 | +3,99% | 3,27% | 10.432.421 |
| 16/10/1996 | 34,11 | 34,41 | 33,87 | 34,35 | +1,05% | 1,57% | 6.621.474 |
| 15/10/1996 | 34,35 | 34,41 | 33,58 | 33,99 | -0,52% | 2,43% | 5.293.238 |
| 14/10/1996 | 33,40 | 34,29 | 33,40 | 34,17 | +2,50% | 2,68% | 3.924.131 |
| 11/10/1996 | 33,22 | 33,58 | 32,98 | 33,34 | +0,36% | 1,80% | 2.754.773 |
| 10/10/1996 | 33,52 | 33,70 | 33,16 | 33,22 | -1,24% | 1,60% | 2.847.206 |
| 09/10/1996 | 33,99 | 34,05 | 33,64 | 33,64 | -1,40% | 1,23% | 3.078.814 |
| 08/10/1996 | 33,46 | 34,41 | 33,22 | 34,11 | +1,60% | 3,57% | 5.993.302 |
| 07/10/1996 | 33,93 | 33,99 | 33,58 | 33,58 | -1,23% | 1,23% | 3.031.654 |
| 04/10/1996 | 33,93 | 34,29 | 33,93 | 33,99 | +0,00% | 1,05% | 4.038.363 |
| 03/10/1996 | 33,64 | 33,99 | 33,46 | 33,99 | +1,06% | 1,60% | 4.247.334 |
| 02/10/1996 | 34,05 | 34,17 | 33,58 | 33,64 | -0,70% | 1,75% | 4.081.541 |
| 01/10/1996 | 33,58 | 34,05 | 33,40 | 33,87 | +0,89% | 1,95% | 4.804.032 |
| 30/09/1996 | 33,46 | 33,64 | 33,34 | 33,58 | +0,18% | 0,89% | 4.277.517 |
| 27/09/1996 | 33,75 | 33,75 | 33,28 | 33,52 | -0,71% | 1,41% | 4.193.048 |
| 26/09/1996 | 32,92 | 33,81 | 32,86 | 33,75 | +2,72% | 2,90% | 8.781.402 |
| 25/09/1996 | 33,10 | 33,22 | 32,68 | 32,86 | -0,36% | 1,62% | 3.819.331 |
| 24/09/1996 | 32,98 | 33,34 | 32,62 | 32,98 | -0,36% | 2,17% | 5.252.576 |
| 23/09/1996 | 32,62 | 33,16 | 32,38 | 33,10 | +1,09% | 2,38% | 4.607.008 |
| 20/09/1996 | 32,68 | 32,80 | 32,62 | 32,74 | +0,18% | 0,55% | 6.565.301 |
| 19/09/1996 | 32,56 | 32,98 | 32,56 | 32,68 | +0,18% | 1,28% | 4.887.243 |
| 18/09/1996 | 32,56 | 32,74 | 32,32 | 32,62 | +0,00% | 1,28% | 4.324.467 |
| 17/09/1996 | 32,56 | 32,86 | 32,50 | 32,62 | +0,37% | 1,10% | 4.010.696 |
| 16/09/1996 | 32,44 | 32,50 | 32,20 | 32,50 | +0,37% | 0,92% | 4.449.598 |
| 13/09/1996 | 32,38 | 32,68 | 32,32 | 32,38 | +0,93% | 1,10% | 4.291.560 |
| 12/09/1996 | 31,97 | 32,38 | 31,79 | 32,08 | +0,37% | 1,87% | 3.235.386 |
| 11/09/1996 | 31,91 | 32,03 | 31,79 | 31,97 | +0,00% | 0,75% | 3.649.555 |
| 10/09/1996 | 31,91 | 32,08 | 31,73 | 31,97 | +0,75% | 1,12% | 4.188.856 |
| 09/09/1996 | 31,13 | 31,73 | 31,07 | 31,73 | +2,50% | 2,11% | 4.299.944 |